Free Trial
$100 Off. Every Year. Lock In MarketBeat All Access at $149
Claim the Rate Lock
Claim MarketBeat All Access Sale Promotion

Globe Life (NYSE:GL) Price Target Cut to $215.00 by Analysts at TD Cowen

Globe Life logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

Globe Life (NYSE:GL - Get Free Report) had its target price decreased by stock analysts at TD Cowen from $225.00 to $215.00 in a report issued on Friday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. TD Cowen's price objective indicates a potential upside of 30.47% from the stock's current price.

Other equities research analysts also recently issued reports about the company. UBS Group set a $165.00 price target on Globe Life in a report on Friday. Weiss Ratings raised shares of Globe Life from a "buy (b-)" rating to a "buy (b)" rating in a report on Wednesday. JPMorgan Chase & Co. boosted their price objective on shares of Globe Life from $193.00 to $195.00 and gave the company an "overweight" rating in a research report on Thursday, October 15th. Morgan Stanley dropped their price objective on shares of Globe Life from $208.00 to $197.00 and set an "overweight" rating on the stock in a research note on Monday, October 5th. Finally, Wells Fargo & Company upped their target price on Globe Life from $190.00 to $191.00 and gave the company an "overweight" rating in a report on Monday, October 12th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and three have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $182.60.

Read Our Latest Analysis on GL

Globe Life Stock Down 2.2%

NYSE:GL opened at $164.79 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.07 and a current ratio of 0.07. The company has a market capitalization of $12.66 billion, a price-to-earnings ratio of 11.02 and a beta of 0.44. Globe Life has a one year low of $127.85 and a one year high of $191.55. The stock has a 50-day simple moving average of $170.48 and a 200 day simple moving average of $167.25.

Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings data on Wednesday, October 21st. The company reported $4.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.90 by ($0.06). Globe Life had a net margin of 18.89% and a return on equity of 19.95%. The firm had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the previous year, the company earned $4.81 EPS. The company's quarterly revenue was up 5.5% compared to the same quarter last year. Sell-side analysts predict that Globe Life will post 15.70 EPS for the current fiscal year.

Globe Life announced that its board has approved a stock repurchase plan on Monday, August 10th that allows the company to buy back $2.50 billion in shares. This repurchase authorization allows the company to buy up to 17.7% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company's leadership believes its shares are undervalued.

Insiders Place Their Bets

In related news, EVP Michael Majors sold 37,000 shares of the company's stock in a transaction dated Wednesday, July 29th. The shares were sold at an average price of $178.64, for a total value of $6,609,680.00. Following the completion of the sale, the executive vice president owned 53,518 shares of the company's stock, valued at $9,560,455.52. This represents a 40.88% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Robert Hensley sold 10,000 shares of the company's stock in a transaction that occurred on Tuesday, September 22nd. The stock was sold at an average price of $170.07, for a total transaction of $1,700,700.00. Following the completion of the sale, the executive vice president directly owned 12,384 shares of the company's stock, valued at approximately $2,106,146.88. This represents a 44.67% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 143,650 shares of company stock valued at $25,793,717 over the last three months. 2.11% of the stock is currently owned by company insiders.

Institutional Trading of Globe Life

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Amundi boosted its holdings in Globe Life by 307.4% during the second quarter. Amundi now owns 162,223 shares of the company's stock worth $28,986,000 after buying an additional 122,402 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Globe Life during the 2nd quarter valued at $4,574,000. Sei Investments Co. lifted its holdings in shares of Globe Life by 49.1% in the first quarter. Sei Investments Co. now owns 71,795 shares of the company's stock valued at $9,993,000 after purchasing an additional 23,632 shares in the last quarter. State Street Corp boosted its position in shares of Globe Life by 2.1% in the second quarter. State Street Corp now owns 3,735,409 shares of the company's stock worth $667,443,000 after buying an additional 76,745 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in shares of Globe Life during the second quarter valued at $17,229,000. Institutional investors own 81.61% of the company's stock.

Globe Life News Summary

Here are the key news stories impacting Globe Life this week:

  • Positive Sentiment: Globe Life reported third-quarter revenue of approximately $1.60 billion, above the $1.56 billion analyst consensus, with revenue up 5.5% year over year. Operating EPS increased to $4.84 from $4.81 a year earlier. Globe Life third-quarter 2026 results
  • Positive Sentiment: Management is targeting $850 million to $950 million in parent excess cash flow for 2027, which could support capital returns, debt reduction or other shareholder-friendly actions. The company projects 2027 EPS of $16.10 to $17.10, a range that includes the $16.51 consensus estimate. Globe Life 2027 outlook
  • Neutral Sentiment: The company’s 2027 EPS guidance of $16.10 to $17.10 implies continued earnings growth, but the broad range suggests uncertainty around operating performance and future underwriting results.
  • Negative Sentiment: Third-quarter operating EPS of $4.84 missed estimates ranging from $4.87 to $4.90. Weaker underwriting income and higher expenses offset gains from increased premiums and investment income. Globe Life Q3 earnings miss
  • Negative Sentiment: Globe Life cut its FY 2026 EPS outlook to $15.35-$15.65, below the $15.72 consensus estimate. Reports also cited losses at Evry Health as a factor pressuring the full-year guidance. Evry Health losses and Globe Life guidance
  • Negative Sentiment: The quarter included a reported underwriting loss of about $6.4 million, raising investor concerns about claims trends, expense control and the company’s ability to convert premium growth into profits. Globe Life underwriting loss analysis

Globe Life Company Profile

(Get Free Report)

Globe Life Inc NYSE: GL is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.

Recommended Stories

Analyst Recommendations for Globe Life (NYSE:GL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Globe Life Right Now?

Before you consider Globe Life, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.

While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines